Electrical impedance spectroscopy of benign and malignant prostatic tissues.

PURPOSE The specificity of current screening methods for prostate cancer is limited and it results in approximately 75% to 80% of patients who undergo biopsy having findings negative for cancer. We used electrical impedance spectroscopy to evaluate how significantly the electrical properties of benign and malignant prostatic tissues differ with the goal of providing clinicians with a new biomarker to aid in diagnosis. MATERIALS AND METHODS We collected freshly excised prostates from 14 men immediately following radical prostatectomy. The prostates were sectioned into 3 mm slices. Electrical property measurements of conductivity and relative permittivity were recorded from each slice using a coaxially configured probe over the frequency range of 1 kHz to 1 MHz. The area probed was marked so that following tissue fixation and slide preparation histological assessment could be correlated directly with the recorded electrical impedance spectroscopy spectra. RESULTS Prostatic adenocarcinoma, benign prostatic hyperplasia, nonhyperplastic glandular tissue and stroma were the primary tissue types probed with electrical impedance spectroscopy. Conductivity ranged from 0.093 S/m at 1 kHz to 0.277 S/m at 1 MHz. Relative permittivity ranged from 8.5 x 10(5) at 1 kHz down to 1.3 x 10(3) at 1 MHz. There were significant conductivity differences between cancer and stroma at all frequencies (p <0.01). There were significant permittivity differences between cancer and benign prostatic hyperplasia at frequencies greater that 92 kHz (p <0.01). Significant correlations were observed between electrical properties, and the concentration of stromal and glandular tissues present in the tissue area histologically assessed. CONCLUSIONS The electrical properties of benign and malignant prostate tissues differ significantly. This should be considered for use as a diagnostic tool. The differences observed between cancer and benign prostatic hyperplasia are especially important since current screening methods do not reliably differentiate between the 2 conditions.

[1]  R. W. Lau,et al.  The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. , 1996, Physics in medicine and biology.

[2]  Kathleen N Lohr,et al.  Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[3]  Paul Geladi,et al.  Non‐invasive and microinvasive electrical impedance spectra of skin cancer – a comparison between two techniques , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[4]  Kathleen N. Lohr,et al.  Screening for Prostate Cancer: An Update of the Evidence , 2002 .

[5]  R. Mah,et al.  Real‐time multiple microsensor tissue recognition and its potential application in the management of prostate cancer , 2006, BJU international.

[6]  W. Catalona.  Prostate-cancer screening. , 2009, The New England journal of medicine.

[7]  Rosalie Nolley,et al.  The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? , 2004, The Journal of urology.

[8]  C P Price,et al.  Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer , 2001, Annals of clinical biochemistry.

[9]  B H Brown,et al.  The use of electrical impedance spectroscopy in the detection of cervical intraepithelial neoplasia , 2006, International Journal of Gynecologic Cancer.

[10]  J. Jossinet,et al.  Classification of breast tissue by electrical impedance spectroscopy , 2006, Medical and Biological Engineering and Computing.

[11]  B. Oakley,et al.  Four‐point electrode measurement of impedance in the vicinity of bovine aorta for quasi‐static frequencies , 2005, Bioelectromagnetics.

[12]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[13]  Harry J de Koning,et al.  Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial , 2002, International journal of cancer.

[14]  K. Foster,et al.  Dielectric properties of tissues and biological materials: a critical review. , 1989, Critical reviews in biomedical engineering.

[15]  Keith D. Paulsen,et al.  Electrical Impedance Spectroscopy of the Human Prostate , 2007, IEEE Transactions on Biomedical Engineering.

[16]  Banu Onaral,et al.  Electrical Properties of Bioelectrodes , 1984, IEEE Transactions on Biomedical Engineering.

[17]  R H Smallwood,et al.  Electrical impedance spectroscopy and the diagnosis of bladder pathology: a pilot study. , 2002, The Journal of urology.

[18]  J. Crowley,et al.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. , 2004, The New England journal of medicine.

[19]  A W Partin,et al.  Bioimpedance: Novel use of a minimally invasive technique for cancer localization in the intact prostate , 1999, The Prostate.